Event Details

  • Event Type: Analysts/Investors Earnings Call
  • Date Held: November 17, 2026
  • Time: 04:30 P.M. (IST)
  • Format: Audio Conference Call (no video recording available)
  • Content Discussed: Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) for Quarter-II of Financial Year 2026-27, ended on September 30, 2026

Availability of Recording

The audio recording has been uploaded to the company's website. The specific link provided is: https://orchid-pharma.b-cdn.net/audios/10049646.mp3

Continuity of Disclosure

This filing is in continuation to earlier intimations made by the company dated November 12 & 16, 2026 regarding the same Analysts/Investors Earnings Call.

Company Representative

  • Designation: Company Secretary & Compliance Officer
  • Membership Number: F10698
  • Signing Date: November 17, 2026 at 19:45:24 IST

Financial Impact

Financial impact not quantified in the disclosure. The filing serves as a compliance notification regarding the availability of earnings call recording.

#Tags: #OrchidPharma #SEBIDisclosure #Regulation30 #EarningsCall #Neutral